Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript March 20, 2025
Arcadia Biosciences, Inc. misses on earnings expectations. Reported EPS is $-2.99 EPS, expectations were $-0.89.
Operator: Good afternoon, and welcome to Arcadia Biosciences Fourth Quarter and Full Year 2024 Financial Results and Business Highlights Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to Mark...
